J&J/Ethicon
This article was originally published in The Tan Sheet
Executive Summary
Wound care division will "phase out production and marketing of selected general wound care product lines - including eye pads, sponges, gauze pads, tapes and cleaners - in the U.S. within the next six months," firm says in July 1 letter to distributors. J&J/Ethicon instead will focus on developing drug/device combination products for advanced wound care, such as Band-Aid liquid bandage and Dermabond topical skin adhesive, which are manufactured by Closure Medical and marketed by J&J (1"The Tan Sheet" March 18, 2002, p. 19). Several Band-Aid products, such as Steri-Pad gauze pads, are affected by the phase-out, which includes 36 brands. J&J/Ethicon plans to close its manufacturing facility in Sherman, Texas by Dec. 31 and says the move will affect roughly 510 employees at the plant...
You may also be interested in...
J&J Band-Aid Liquid Bandage Labeling Stresses “Fast Healing” Benefits
Band-Aid Liquid Bandage is reaching food, drug and mass shelves now after shipping in late February, according to Johnson & Johnson Consumer Products
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.